The first objective is to explore whether epo regulation and expression, at the age of two weeks after birth and three to six months post-term, are associated with the course of Hb levels. Furthermore, we will assess if epo regulation and expression…
ID
Source
Brief title
Condition
- Other condition
- Anaemias nonhaemolytic and marrow depression
- Gastrointestinal inflammatory conditions
Synonym
Health condition
neurologische ontwikkeling
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome measure will be epo regulation and expression at various
ages: baseline epo concentration in umbilical cord blood, baseline DNA
methylation and gene expression in placental tissue, epo concentration in blood
at the age of two weeks after birth, the degree of DNA methylation in
intestinal cells isolated from feces at the age of two weeks after birth, and
the degree of DNA methylation in intestinal cells isolated from feces at the
age of three to six months post-term. Additionally, if one of the included
infants developed NEC and needs surgery, then a small part of the removed
intestine will be analysed in laboratory for intestinal epo gene expression.
Furthermore, we will use Hb levels assessed during standard care and collect
information (number and volume) regarding RBC transfusions during the first
four weeks of life. Cerebral and intestinal oxygen saturation during the first
four weeks after birth and urinary isoprostane concentrations will also be
determined.
Secondary outcome
Secondary outcomes will be cerebral and intestinal tissue oxygen saturation,
urinary intestinal fatty acid binding protein concentration before and after
RBC transfusion, and the prevalence of NEC and its grading up to 40 weeks
postmenstrual age. Furthermore, we will assess the neurological condition using
the assessment of general movements (GMs) before and after the first RBC
transfusion, and the neurological outcome at the age of three months (+/- 2
weeks) post-term, based on the motor optimality score (MOS) of the quality of
the GMs.
Background summary
Neonatal anemia is common in preterm infants. Anemia may lead to hypoxia,
possibly resulting in cell damage. A red blood cell (RBC) transfusion is an
intervention aiming to rapidly improve oxygen transport to vital organs, such
as the brain and the gut.
Anemia and RBC transfusions result in low and high organ oxygenation
respectively. Both might be harmful, and especially high variation in
oxygenation may lead to damage in vulnerable organs, such as the brain and the
gut. As erythropoiesis is partly upregulated by hypoxia, there might be an
association between these oxygenation values and the expression of
erythropoietin (epo), which is the essential growth factor for the production
of erythrocytes. Also, the expression of the epo receptor in the intestinal
enterocytes might influence growth and development of the gastrointestinal
tract, which may protect against necrotizing enterocolitis (NEC) in preterm
born infants. Epo may also provide neuroprotection for different pathways of
brain injury. In the brain, epo, therefore functions as both an important
growth factor and a neuroprotective agent.
The expression of epo is controlled by DNA methylation. DNA methylation, i.e.
adding a methyl group to the DNA molecules, results in inactivity of the gene.
This DNA methylation has been shown to partially depend on oxygen and nutrient
supply. Anemia leads to decreased oxygen transport and decreased organ
oxygenation, whereas RBC transfusion increases oxygenation. It is unknown
whether anemia and/or RBC transfusion are related to the expression of epo in
gut cells through these various levels of oxygenation. We will therefore
explore whether epo regulation and expression in intestinal cells may be
associated with the course of hemoglobin (Hb) levels. Furthermore, we will
explore if epo regulation and expression may also be associated with anemia,
RBC transfusions, oxidative stress, and organ oxygenation in the neonatal
period. Secondary, we will evaluate the clinical consequences and the
neurological outcome of the variable oxygenation levels.
Study objective
The first objective is to explore whether epo regulation and expression, at the
age of two weeks after birth and three to six months post-term, are associated
with the course of Hb levels. Furthermore, we will assess if epo regulation and
expression are also associated with anemia, RBC transfusions, oxidative stress,
and cerebral and intestinal oxygenation in preterm infants during the early
neonatal period.
Our second objective is to evaluate the association between various oxygenation
levels and hypoxic intestinal cell damage, the prevalence of NEC and its
grading up to 40 weeks postmenstrual age, the neurological condition during
anemia and after RBC transfusion, and the neurological outcome at three months
post-term.
Study design
Prospective observational cohort study.
Study burden and risks
This study cannot be performed in another population, as the lack of knowledge
about the possible association between anemia and RBC transfusions, and the
expression of epo in gut cells, through the various levels of oxygenation is
typical for preterm infants.
Burden: All infants participating in the study are subjected to routine
neonatal intensive care. This study is an observational study, implying minimal
extra care; therefore there is minimal burden and risk associated with
participation.
First, the fecal samples will be collected from the diaper, using a scooper.
The samples will be collected during routine handling moments, so the infant
will not be disturbed. Parents will be asked to send a feces sample of their
infant around the age of three to six months post-term. They will receive a
kit, which contains a preservation buffer. The stool sample is stable at room
temperature for months and can be send by mail.
Second, we intend to measure the epo concentration in the second week of life
to validate the DNA methylation in the fecal samples, by sampling 100
microliter extra blood, which is about three drops, only when blood will be
drawn for clinical purposes. The 100 microliter umbilical cord blood will be
sampled after birth.
Third, monitoring of cerebral and intestinal regional tissue oxygen saturation
is routine clinical care in all preterm infants admitted to the NICU at the
UMCG, and near-infrared spectroscopy (NIRS) is a continuous and non-invasive
method to use. For the purpose of this study possibly extra NIRS measurements
will be needed in the third and fourth week of life, during the time around and
after the infant receives an RBC transfusion.
Fourth, the urinary samples will be collected non-invasively by a small gauze
in the diaper. The samples will be collected during routine handling moments,
so the infant will not be disturbed.
Fifth, evaluating GMs is a widely accepted non-invasive method to assess the
neurological neonatal outcome. Before and after the first RBC transfusion the
infant will be video-recorded for 30 minutes, and at the age of three months
(+/- 2 weeks) post-term for 10 minutes, with the infant in an actively awake
state, comfortably dressed, with uncovered arms and legs. The camera will be
placed in a way that caregivers are not hindered by the camera and do not lose
sight on the monitor. Therefore, video recording GMs will not interfere with
clinical care.
Benefits and risks: The study may provide more insight in the mechanism of the
epo regulation and expression, as a neuroprotective agent, and as a factor
influencing growth and development of the gastrointestinal tract. It may
elucidate the relation between epo regulation and expression on the one hand
and anemia and RBC transfusions and subsequent oxygenation of organs on the
other. This might be of importance for a normal neurological development and to
prevent NEC, increasing quality of life of preterm infants.
Hanzeplein 1
Groningen 9713 GZ
NL
Hanzeplein 1
Groningen 9713 GZ
NL
Listed location countries
Age
Inclusion criteria
- gestational age < 32 weeks
- before 7 days of age
- written informed consent by legal representative(s)
Exclusion criteria
- Chromosomal abnormality (e.g. trisomy 13, 18, 21)
- Perinatal asphyxia resulting in Apgar score (AS) < 5 at five minutes
postpartum
- Major congenital malformations that increase the risk of death or adverse
neurodevelopmental outcome (congenital cerebral malformations, congenital heart
diseases excluding patent ductus arteriosus)
- Intraventricular and periventricular hemorrhage > grade 2 according to
Papile, prior to inclusion
- Diagnosis of NEC prior to inclusion
- Alloimmune hemolytic disease, sickle-cell disease or thalassemia
- Any received RBC transfusions prior to inclusion
- Inability to understand Dutch by the parents
- Parents expressing strong philosophical or religious objections to
transfusion
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL62348.042.17 |
Other | NTR 6625 / NL6447 |